Bleeding tendencies & abnormal bleeding involving systemic hyperfibrinolysis. Symptomatic treatment of eczema, urticaria, drug eruptions or toxicoderma; tonsillitis, pharyngolaryngitis. Pain in the oral cavity or mucosal aphtha in case of stomatitis.
Not to be inj IM. Not to be given in patients w/ history of convulsion, disseminated intravascular coagulation w/ predominant coagulation system activation. Renal & upper urinary tract haematuria; risk factors for thromboembolic disease. Concomitant use of OCs. Renal insufficiency. Pregnancy & lactation.
Sign Out
